No Data
Pinning Down Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) P/E Is Difficult Right Now
Sichuan Hebang Biotechnology (603077.SH): has actually repurchased 0.59% of the company's shares.
On February 6, Glonghui reported that Sichuan Hebang Biotechnology (603077.SH) announced that on February 5, 2025, the company completed the share buyback, having repurchased 51,843,900 shares, accounting for 0.59% of the company's total share capital, with a maximum buyback price of 2.30 yuan/share, a minimum buyback price of 1.88 yuan/share, and an average buyback price of 1.93 yuan/share, utilizing a total of 100,000,056.45 yuan.
Hebang Biotech 2024 Annual Results Pre-Reduction Announcement
Does Sichuan Hebang Biotechnology (SHSE:603077) Have A Healthy Balance Sheet?
Sichuan Hebang Biotechnology (603077.SH): Glyphosate production line running at full capacity in the fourth quarter.
Gelonghui reported on January 3 that Sichuan Hebang Biotechnology (603077.SH) stated on the investor interaction platform that the company's Glyphosate production line is running at full capacity in the fourth quarter, and the financial situation related to gross margin should refer to the company's regular reports disclosed later.
Individual Investors Among Sichuan Hebang Biotechnology Corporation Limited's (SHSE:603077) Largest Stockholders and Were Hit After Last Week's 3.9% Price Drop
Sichuan Hebang Biotechnology (SHSE:603077) Has Some Way To Go To Become A Multi-Bagger
